Gregory, T.A., Wilson, C., Duncan, A., Turnbull, D., Cole, S.R., & GP, Y., 2011. Demographic, social cognitive and social. BMC Public Health, 11(38).

Ward, P.R., Javanparast, S., Ah Matt, M.L., Martini, A., Tsourtos, G., Cole, S.R., Gill, T.K., Aylward, P., Baratiny, G., Jiwa, M., et al., 2011. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia. Australian and New Zealand Journal of Public Health, 35(1), 61-65.

Martini, A., Javanparast, S., Ward, P.R., Cole, S.R., Aylward, P., Baratiny, G., Gill, T., Tsourtos, G., Misan, G., Wilson, C., et al., 2011. Screening for colorectal cancer in remote, rural and metropolitan South Australia: analysis of the National Bowel Cancer Screening Program data. Public Health Bulletin South Australia, 8(1), 49-55.

Martini, A., Javanparast, S., Ward, P.R., Baratiny, G., Gill, T.K., Cole, S.R., Tsourtos, G., Aylward, P., Jiwa, M., Misan, G., et al., 2011. Colorectal cancer screening in rural and remote area: analysis of the National Bowel Cancer Screening Program data for South Australia. Rural and Remote Health, 11(2).

Wilson, C., Flight, I., Zajac, I., Turnbull, D., Young, G.P., Cole, S.R., & Gregory, T.A., 2010. Protocol for population testing of an internet-based Personalised Decision Support system for colorectal cancer screening. BMC Medical Informatics and Decision Making, 1-8.

Lane, J.M., Chow, E.C., Young, G.P., Good, N., Smith, A.T., Bull, J.A., Sandford, J.J., Morcom, J.M., Bampton, P.A., & Cole, S.R., 2010. Interval Fecal Immunochemical Testing in a Colonoscopic Surveillance Program Speeds Detection of Colorectal Neoplasia. Gastroenterology, 139, 1918-1926.

Javanparast, S., Ward, P.R., Young, G.P., Wilson, C., Carter, S., Misan, G., Cole, S.R., Jiwa, M., Tsourtos, G., Martini, A., et al., 2010. How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies. Preventive Medicine, 50, 165-172.

Javanparast, S., Ward, P.R., Cole, S.R., Gill, T.K., Ah Matt, M.L., Aylward, P., Baratiny, G., Jiwa, M., Martini, A., Mison, G., et al., 2010. A cross-sectional analysis of participation in National Bowel Cancer Screening Program in Adelaide by age, gender and geographical location of residence. Australasian Medical Journal, 1(1), 141-146.

Zajac, I., Whibley, A., Cole, S.R., Byrne, D.T., Guy, J.R., Morcom, J.M., & Young, G.P., 2010. Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis. Journal of Medical Screening, 17, 19-24.

Cole, S.R., Zajac, I., Gregory, T.A., Mehaffey, S.J., Roosa, N., Turnbull, D., Esterman, A., & Young, G.P., 2010. Psychosocial variables associated with colorectal cancer screening in South Australia. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 302-309.

Martini, A., Javanparast, S., Ward, P.R., Baratiny, G., Gill, T.K., Cole, S.R., Tsourtos, G., Aylward, P., Jiwa, M., Misan, G., et al., 2011. Colorectal cancer screening in rural and remote area: analysis of the National Bowel Cancer Screening Program data for South Australia. Rural and Remote Health, 11(2).

Gregory, T.A., Wilson, C., Duncan, A., Turnbull, D., Cole, S.R., & GP, Y., 2011. Demographic, social cognitive and social. BMC Public Health, 11(38).

Martini, A., Javanparast, S., Ward, P.R., Cole, S.R., Aylward, P., Baratiny, G., Gill, T., Tsourtos, G., Misan, G., Wilson, C., et al., 2011. Screening for colorectal cancer in remote, rural and metropolitan South Australia: analysis of the National Bowel Cancer Screening Program data. Public Health Bulletin South Australia, 8(1), 49-55.

Ward, P.R., Javanparast, S., Ah Matt, M.L., Martini, A., Tsourtos, G., Cole, S.R., Gill, T.K., Aylward, P., Baratiny, G., Jiwa, M., et al., 2011. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia. Australian and New Zealand Journal of Public Health, 35(1), 61-65.

Javanparast, S., Ward, P.R., Cole, S.R., Gill, T.K., Ah Matt, M.L., Aylward, P., Baratiny, G., Jiwa, M., Martini, A., Mison, G., et al., 2010. A cross-sectional analysis of participation in National Bowel Cancer Screening Program in Adelaide by age, gender and geographical location of residence. Australasian Medical Journal, 1(1), 141-146.

Cole, S.R., Zajac, I., Gregory, T.A., Mehaffey, S.J., Roosa, N., Turnbull, D., Esterman, A., & Young, G.P., 2010. Psychosocial variables associated with colorectal cancer screening in South Australia. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 302-309.

Javanparast, S., Ward, P.R., Young, G.P., Wilson, C., Carter, S., Misan, G., Cole, S.R., Jiwa, M., Tsourtos, G., Martini, A., et al., 2010. How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies. Preventive Medicine, 50, 165-172.

Zajac, I., Whibley, A., Cole, S.R., Byrne, D.T., Guy, J.R., Morcom, J.M., & Young, G.P., 2010. Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis. Journal of Medical Screening, 17, 19-24.

Wilson, C., Flight, I., Zajac, I., Turnbull, D., Young, G.P., Cole, S.R., & Gregory, T.A., 2010. Protocol for population testing of an internet-based Personalised Decision Support system for colorectal cancer screening. BMC Medical Informatics and Decision Making, 1-8.

Lane, J.M., Chow, E.C., Young, G.P., Good, N., Smith, A.T., Bull, J.A., Sandford, J.J., Morcom, J.M., Bampton, P.A., & Cole, S.R., 2010. Interval Fecal Immunochemical Testing in a Colonoscopic Surveillance Program Speeds Detection of Colorectal Neoplasia. Gastroenterology, 139, 1918-1926.

Duncan, A., Wilson, C., Cole, S.R., Mikocka-Walus, A., Turnbull, D., & Young, G.P., 2009. Demographic associations with stage of readiness to screen for colorectal cancer. Health Promotion Journal of Australia, 20(1), 7-12.

Wilson, C., Flight, I., Hart, E., Turnbull, D., Cole, S.R., & Young, G.P., 2008. Internet access for delivery of health information to South Australians older than 50. Australian and New Zealand Journal of Public Health, 32(2), 174-176.

Cole, S.R., Smith, A., Wilson, C., Turnbull, D., Esterman, A.J., & Young, G.P., 2007. An advance notification letter increases participation in colorectal cancer screening. Journal of Medical Screening, 14(2), 73-75.

Young, G.P. & Cole, S.R., 2007. New stool screening tests for colorectal cancer. Digestion, 76(1), 26-33.

Smith, A.T., Young, G.P., Cole, S.R., & Bampton, P.A., 2006. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer, 107(9), 2152-2159.

Worthley, D., Smith, A.T., Bampton, P.A., Cole, S.R., & Young, G.P., 2006. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. European Journal of Gastroenterology and Hepatology, 18(10), 1079-1083.

Worthley, D., Cole, S.R., Esterman, A.J., Mehaffey, S.J., Roosa, N., Smith, A.T., Turnbull, D., & Young, G.P., 2006. Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Internal Medicine Journal, 36(9), 607-610.

Bampton, P.A., Sandford, J.J., Cole, S.R., Smith, A., Morcom, J., Cadd, B., & Young, G.P., 2005. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology. Gut, 54(6), 803-806.

Young, G.P., Bampton, P.A., Cole, S.R., Morcom, J., Smith, A., Turnbull, D., & Wilson, C., 2004. Screening for colorectal cancer. Public Health Bulletin South Australia, 1, 22-25.

Cole, S.R., Young, G.P., Esterman, A.J., Cadd, B., & Morcom, J., 2003. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. Journal of Medical Screening, 10(3), 117-122.

Young, G.P., St John, J.B., Cole, S.R., Bielecki, B.E., Pizzey, C., Sinatra, M.A., Cadd, B., & Morcom, J., 2003. Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin. Journal of Medical Screening, 10(3), 123-128.

Cole, S.R., Young, G.P., Byrne, D.T., & Guy, J.R., 2002. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. Journal of Medical Screening, 9(4), 147-152.

Cole, S.R. & Young, G.P., 2001. Effect of dietary restriction on particpation in faecal occult blood test screening for colorectal cancer. Medical Journal of Australia, 175, 195-198.

Ferrao, P., Sincock, P., Cole, S.R., & Ashman, L., 2001. Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia. Leukemia Research, 25(5), 395-405.

Flight, I., Wilson, C., Duszynski, A., Turnbull, D., Cole, S.R., & Young, G.P., 2005. Electronic tailoring of information on the basis of perceived risk and health-beliefs: a method for increasing uptake of colorectal cancer screening?. Tailoring health messages: bridging the gap between social and humanistic perspectives on health communication, 31-35.

Bampton, P.A., Looker, J., Smith, A., Cole, S.R., & Young, G.P., 2005. Negative interval fit in a colonoscopic based screening program identifies subjects at lower risk of recurrent pathology. Journal of Gastroenterology and Hepatology, 20(S1), A9-A9.

Worthley, D., Cole, S.R., & Young, G.P., 2005. Fecal DNA for colorectal-cancer screening. New England Journal of Medicine, 352(13), 1384-1385.

Ward, P.R., Javanparast, S., Gill, T., Cole, S.R., Tsourtos, G., Young, G.P., Wilson, C., & Baratiny, G., 2009. The equity of bowel cancer screening in South Australia: an ecological analysis. PHAA 39th Annual Conference: making a difference, intervening to improve health outcomes.

Chow, E.C., Lane, J.M., Cole, S.R., Bampton, P.A., & Young, G.P., 2008. The value of a colonoscopy-based surveillance program (CSP) for people at increased risk for colorectal cancer (CRC). Gastroenterology, 134(Suppl. 1), A604-A604.

Chow, E.C., Lane, J.M., Smith, A., Cole, S.R., Morcom, J.M., Bampton, P.A., & Young, G.P., 2008. The value of interval fecal occult blood testing in colonoscopy-based surveillance program (CSP) for people at increased risk for colorectal cancer. Gastroenterology, 134(Suppl. 1), A87-A87.

Cole, S.R., Smith, A., Upton, J.M., & Young, G.P., 2007. Is single stool sampling as effective as two stool sampling in fecal immunochemical test based screening for colorectal cancer?. Gastroenterology, 132(4 Suppl. 2), A314-A314.

Cole, S.R., Smith, A.T., Wilson, C., Turnbull, D., Esterman, A.J., & Young, G.P., 2006. An advance notification letter increases participation in a fecal immunochemical test-based colorectal cancer screening program. Gastroenterology, 130(4), A187-A187.

Chow, E.C., Smith, A., Cole, S.R., Bampton, P.A., Sandford, J.J., Morcom, J., & Young, G.P., 2006. Value of interval faecal occult blood testing in a colonoscopic based surveillance programme for people at high risk for colorectal cancer [Abstract]. Journal of Gastroenterology and Hepatology, 21(Suppl. 4), A284-A284.

Duszynski, A., Flight, I., Wilson, C., Turnbull, D., Cole, S.R., & Young, G.P., 2005. Intersecting electronic decision support with user modelling in a web-based consumer decision aid for colorectal cancer screening. User Modelling 2005: 10th International Conference on User Modelling, 24-29 July, 2005:www1-www4.

Worthley, D.L., Bampton, P.A., Cole, S.R., Smith, A., & Young, G.P., 2005. Many participants in FOBT screening have a higher than average risk for colorectal cancer [Abstract]. Journal of Gastroenterology and Hepatology: Colon, Rectum and Small Bowel, 20(S1), A30-A30.

Worthley, D., Bampton, P.A., Cole, S.R., Smith, A.T., & Young, G.P., 2005. Many participants in population screening by FOBT have higher than average risk for colorectal cancer. Gastroenterology, 128(4), A572-A572.

Smith, A., Cole, S.R., & Young, G.P., 2005. How many colonoscopies are needed to detect advanced neoplasia in population screening using fecal immunochemical occult blood tests? [Abstract]. Journal of Gastroenterology and Hepatology: Colon, Rectum and Small Bowel, 20(S1), A28-A28.

Worthley, D., Cole, S.R., Mehaffey, S.J., Smith, A., Turnbull, D., & Young, G.P., 2004. A questionnaire based assessment of barriers to participation in faecal occult blood test screening for colorectal cancer: why they choose to refuse [Abstract]. Journal of Gastroenterology and Hepatology: Colon Rectum and Small Bowel, 19(S4), A196-A196.

Worthley, D.L., Cole, S.R., Mehaffey, S.J., Smith, A., Turnbull, D., & Young, G.P., 2004. A questionnaire based assessent of barriers to participation in faecal occult blood test screening for colorectal cancer: why they choose to refuse. Journal of Gastroenterology and Hepatology, 19(Suppl. 4), A196-A196.

Worthley, D.L., Cole, S.R., Mehaffey, S.J., Smith, A., Turnbull, D., & Young, G.P., 2004. The participants' perception of faecal occult blood test screening for colorectal cancer: a questionnaire based study. Journal of Gastroenterology and Hepatology, 19(Suppl. 4), A219-A219.

Smith, A.T., Young, G.P., Cole, S.R., Morcom, J.M., Chandler, H.M., & Lapointe, L.C., 2004. A quantifiable faecal immunochemical test (FIT) for haemoglobin facilitates balancing sensitivity with specifity when screening for colorectal cancer (Abstract). Gastroenterology, 126(4 Suppl. 2), A199-A199.

Smith, A., Cole, S.R., Young, G.P., Morcom, J., Lapointe, L.C., & Chandler, H.M., 2004. A quantifiable faecal immunochemical test (FIT) for haemoglobin facilitates balancing sensitivity with specificity when screening for colorectal cancer. Journal of Gastroenterology and Hepatology, 19(Suppl. 4), A195-A195.

Cole, S.R., Young, G.P., Roosa, N., Mehaffey, S.J., Smith, A., Esterman, A.J., Severino, J., & Turnbull, D., 2004. Behavioural differences between participants and nonparticipants in colorectal cancer screening. Journal of Gastroenterology and Hepatology, 19(Suppl. 4), A198-A198.

Cole, S.R., Turnbull, D., Smith, A., Mehaffey, S.J., Severino, J., & Young, G.P., 2004. Psychosocial and demographic differences between participants and non-participants in bowel cancer screening. International Journal of Behavioral Medicine, 11(Suppl), 302-302.

Cole, S.R., Cadd, B., Smith, A., Morcom, J., & Young, G.P., 2004. Colorectal cancer screening behaviour is influenced by screening test technology. International Journal of Behavioral Medicine, 11(Suppl), 69-69.

Bampton, P.A., Sandford, J.J., Cole, S.R., Smith, A., Morcom, J., Cadd, B., & Young, G.P., 2004. Interval fecal occult blood testing in a colonoscopy-based colorectal cancer surveillance program detects additional pathology. Gastroenterology, 126(4).

Young, G.P., Cole, S.R., Roosa, N., Mehaffey, S.J., Smith, A.T., Esterman, A.J., Severino, J., & Turnbull, D., 2004. Behavioural differences between participants and non-participants in colorectal cancer (CRC) screening. Gastroenterology, 126(4), A194-A194.

Smith, A., Cadd, B., Morcom, J., Byrne, D.T., Guy, J.R., Cole, S.R., & Young, G.P., 2003. Relationship between ongoing participation in colorectal cancer screening and method of invitation [Abstract]. Gastroenterology, 124(4), A56-A56.

Ramnath, G.J., Olesnicki, A., Cole, S.R., Esterman, A.J., Bampton, P.A., & Young, G.P., 2003. Yield of significant neoplasia in three clinically indicated settings for colonoscopy [Abstract]. Gastroenterology, 124(4), A647-A648.

Cole, S.R., Smith, A., Bampton, P.A., Sandford, J.J., Morcom, J., & Young, G.P., 2003. Screening for colorectal cancer: direct comparison of a brush-sampling fecal immunochemical test for hemoglobin with hemoccult [Abstract]. Gastroenterology, 124(4), A80-A80.

Smith, A., Cole, S.R., Morcom, J., Sandford, J.J., Bampton, P.A., & Young, G.P., 2003. Colorectal cancer screening: direct comparison of a brush-sampling faecal immunochemical test for haemoglobin with a guaiac FOBT [Abstract]. Journal of Gastroenterology and Hepatology, 18(Suppl. 2), B24-B24.

Cole, S.R., Sandford, J.J., Cadd, B., Young, G.P., & Bampton, P.A., 2002. Yield of a colonoscopic based surveillance program is enhanced by interval faecal occult blood testing [Abstract]. Journal of Gastroenterology and Hepatology, 17(S5), A96-A96.

Cole, S.R., Roosa, N., Mehaffey, S.J., Young, G.P., & Turnbull, D., 2002. Attitudes towards colorectal cancer screening [Abstract]. Journal of Gastroenterology and Hepatology, 17(S5), A119-A119.

Bampton, P.A., Sandford, J.J., Cadd, B., Cole, S.R., & Young, G.P., 2002. Interval annual faecal occult blood testing detects further lesions in a colonoscopy-based screening surveillance program (Abtract). Gastroenterology, 122(Suppl. 4), A589-A590.

Cole, S.R., Smith, A., Cadd, B., Morcom, J., Byrne, D., Guy, J.R., & Young, G.P., 2002. Screening for colorectal cancer: population participation and yield over time [Abstract]. Journal of Gastroenterology and Hepatology, 17(S5), A122-A122.

Young, G.P., St John, J.B., Cole, S.R., Sinatra, M.A., Bielecki, B.E., Bennett, J., Warren, S., & Pizzey, C., 2002. Sensitivity and specificity for adenomas and cancers of a new quantifiable occult blood test (!nSure®). Journal of Gastroenteroloy and Hepatology, 17(S5), A122-A122.

Young, G.P., Cole, S.R., Cadd, B., & Morcom, J., 2002. Population participation in screening improves markedly using an immunochemical fecal occult blood test with simplified fecal sampling (Abstract). Gastroenterology, 122(Suppl. 4), A484-A484.

Ramnath, G.J., Bampton, P.A., Sandford, J.J., Cole, S.R., & Young, G.P., 2002. Screening colonoscopy vs faecal occult blood testing: what is the yield?. Journal of Gastroenterology and Hepatology, 17(Suppl5), A101-A101.

Young, G.P., Cole, S.R., Cadd, B., & Morcom, J., 2002. Participation in colon cancer screening improves using a faecal occult blood test with improved technology [Abstract]. Journal of Gastroenterology and Hepatology, 17(S5), A120-A120.

Cole, S.R., Sandford, J.J., Cadd, B., Bennett, J., Young, G.P., & Bampton, P.A., 2001. Interval fecal occult blood testing in a colonoscopy based screening program (Abstract). Gastroenterology, 120(5), A603-A603.

Cole, S.R., Cadd, B., Sandford, J.J., Young, G.P., & Bampton, P.A., 2001. Interval faecal occult blood testing in a colonoscopy based screening program (Abstract). Journal of Gastroenterology and Hepatology, 16, A17-A17.

Young, G.P., St John, J.B., Sinatra, M.A., Cole, S.R., Bielecki, B.E., Bennett, J., & Warren, S., 2001. Evaluation of a quantifiable immunochemical fecal occult test with simplified fecal sampling (Abstract). Gastroenterology, 120(5), A599-A599.